Projected prevalence of age-related macular degeneration in Scandinavia 2012-2040

Acta Ophthalmologica
Haakon Lindekleiv, Maja G Erke

Abstract

To project the number of persons with late age-related macular degeneration (AMD) in Scandinavia through 2040. Age- and sex-specific prevalence rates of late AMD (choroidal neovascularization and geographic atrophy) from the European Eye Study and the Eye Diseases Prevalence Research Group were applied to the projected Danish, Norwegian and Swedish population from 2012 to 2040. A total of 187 000 persons aged ≥65 years in Scandinavia are currently affected by late AMD: 47 000 in Denmark, 43 000 in Norway and 97 000 in Sweden. Owing to an ageing population, the number of persons affected by late AMD will increase 75% to 328 000 in 2040. The number of patients with late AMD in Scandinavia is expected to increase substantially over the next three decades, resulting in increased demand for ophthalmic health services.

References

Jul 6, 2002·BMJ : British Medical Journal·Hugh R TaylorJohn J McNeil
Apr 14, 2004·Archives of Ophthalmology·Nathan CongdonUNKNOWN Eye Diseases Prevalence Research Group
Apr 14, 2004·Archives of Ophthalmology·David S FriedmanUNKNOWN Eye Diseases Prevalence Research Group
Apr 12, 2006·Archives of Ophthalmology·Cristina A AugoodAstrid E Fletcher
Sep 13, 2006·Acta Ophthalmologica Scandinavica·Olafur M BjörnssonBettina Kinge
Dec 13, 2006·American Journal of Ophthalmology·Eleftherios AnastasopoulosAnne L Coleman
Mar 14, 2007·Archives of Ophthalmology·William G ChristenCharles H Hennekens
Jun 14, 2008·The New England Journal of Medicine·Rama D JagerJoan W Miller
Jul 26, 2008·Annals of Epidemiology·Rihong CongBin Wang
Nov 26, 2008·Lancet·Hanna R ColemanEmily Y Chew
Apr 15, 2009·Archives of Ophthalmology·David B ReinUNKNOWN Vision Health Cost-Effectiveness Study Group
May 13, 2009·Archives of Ophthalmology·Elaine W-T ChongRobyn H Guymer
Sep 11, 2009·Acta Ophthalmologica·Anja TuulonenMarkku Perkola
Nov 21, 2009·Acta Ophthalmologica·Johan H SelandAstrid E Fletcher
Jan 12, 2011·Archives of Ophthalmology·Ronald KleinJinan B Saaddine
Mar 31, 2011·Investigative Ophthalmology & Visual Science·Robert P FingerHendrik P N Scholl

❮ Previous
Next ❯

Citations

Jun 14, 2013·The British Journal of Ophthalmology·Maja G ErkeInger Njølstad
Mar 26, 2014·Current Opinion in Ophthalmology·Annette Rasmussen, Birgit Sander
Jul 31, 2013·Acta Ophthalmologica·Anders Kvanta, Monika K Grudzinska
Jun 6, 2016·Ageing Research Reviews·Yousif SubhiTorben Lykke Sørensen
Jul 16, 2015·PloS One·Helene Bæk JuelMogens Holst Nissen
Aug 20, 2016·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·C BrandlR P Finger
Jul 15, 2015·Nutrients·Alina Adriana IvanescuAlfredo García-Layana
Oct 8, 2019·Ophthalmic Surgery, Lasers & Imaging Retina·Maté StrehoAudrey Giocanti-Aurégan
Nov 20, 2016·Acta Ophthalmologica·Yousif Subhi, Torben Lykke Sørensen
Apr 29, 2020·Ophthalmology·Tyler Hyungtaek RimUNKNOWN Asian Eye Epidemiology Consortium
Aug 17, 2021·Acta Medica Lituanica·Ho Hin Ma, Rasa Liutkevičienė

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.